Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 6 | 2020 | 255 | 2.080 |
Why?
|
| Bacteroides | 2 | 2021 | 54 | 1.370 |
Why?
|
| Crohn Disease | 3 | 2022 | 322 | 1.260 |
Why?
|
| Colitis | 4 | 2021 | 344 | 0.960 |
Why?
|
| Fecal Microbiota Transplantation | 3 | 2022 | 161 | 0.810 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2021 | 26 | 0.800 |
Why?
|
| Colectomy | 3 | 2020 | 290 | 0.780 |
Why?
|
| Colon | 2 | 2021 | 689 | 0.700 |
Why?
|
| Methotrexate | 1 | 2022 | 1027 | 0.640 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2021 | 352 | 0.630 |
Why?
|
| Interleukins | 1 | 2021 | 340 | 0.630 |
Why?
|
| Dysbiosis | 1 | 2018 | 150 | 0.570 |
Why?
|
| Disease | 1 | 2018 | 159 | 0.560 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2017 | 82 | 0.560 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 440 | 0.530 |
Why?
|
| Feces | 3 | 2022 | 863 | 0.530 |
Why?
|
| Lipase | 1 | 2016 | 122 | 0.500 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2021 | 963 | 0.480 |
Why?
|
| Mercaptopurine | 1 | 2014 | 131 | 0.460 |
Why?
|
| Antimetabolites | 1 | 2014 | 77 | 0.460 |
Why?
|
| Inflammation | 2 | 2021 | 2527 | 0.450 |
Why?
|
| Allopurinol | 1 | 2014 | 86 | 0.440 |
Why?
|
| Immunosuppressive Agents | 2 | 2022 | 1445 | 0.420 |
Why?
|
| Bifidobacterium | 2 | 2021 | 63 | 0.360 |
Why?
|
| Dextran Sulfate | 2 | 2021 | 70 | 0.350 |
Why?
|
| Child | 13 | 2022 | 30418 | 0.330 |
Why?
|
| Clostridium Infections | 2 | 2022 | 261 | 0.290 |
Why?
|
| Phenotype | 1 | 2017 | 6465 | 0.260 |
Why?
|
| Brain | 1 | 2018 | 4257 | 0.250 |
Why?
|
| Adolescent | 7 | 2022 | 32577 | 0.200 |
Why?
|
| Delayed Diagnosis | 2 | 2022 | 152 | 0.190 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2022 | 508 | 0.180 |
Why?
|
| Dipeptides | 1 | 2021 | 98 | 0.180 |
Why?
|
| Child, Preschool | 5 | 2022 | 16978 | 0.170 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 390 | 0.170 |
Why?
|
| Goblet Cells | 1 | 2021 | 119 | 0.170 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2021 | 195 | 0.170 |
Why?
|
| Serotonin | 1 | 2020 | 293 | 0.160 |
Why?
|
| Bacteria | 2 | 2022 | 650 | 0.150 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2018 | 19 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2021 | 1124 | 0.150 |
Why?
|
| Probiotics | 1 | 2021 | 239 | 0.150 |
Why?
|
| Humans | 18 | 2022 | 270946 | 0.150 |
Why?
|
| Disease Progression | 2 | 2020 | 6893 | 0.140 |
Why?
|
| Infant, Newborn | 2 | 2022 | 8591 | 0.140 |
Why?
|
| Granuloma | 1 | 2018 | 159 | 0.140 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 78 | 0.140 |
Why?
|
| Intestines | 1 | 2021 | 731 | 0.130 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 326 | 0.130 |
Why?
|
| Retrospective Studies | 5 | 2022 | 39694 | 0.130 |
Why?
|
| Salmonella | 1 | 2015 | 35 | 0.120 |
Why?
|
| Cytokines | 2 | 2021 | 2836 | 0.120 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 721 | 0.120 |
Why?
|
| Salmonella Infections | 1 | 2015 | 43 | 0.120 |
Why?
|
| Guanine Nucleotides | 1 | 2014 | 26 | 0.120 |
Why?
|
| Thionucleotides | 1 | 2014 | 67 | 0.120 |
Why?
|
| Infant | 2 | 2022 | 13913 | 0.120 |
Why?
|
| Dendritic Cells | 1 | 2021 | 1108 | 0.120 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2015 | 113 | 0.110 |
Why?
|
| Pancreatitis | 1 | 2016 | 292 | 0.110 |
Why?
|
| Heart Transplantation | 1 | 2019 | 904 | 0.110 |
Why?
|
| Hospitalization | 1 | 2022 | 2200 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 4505 | 0.100 |
Why?
|
| Germ-Free Life | 2 | 2022 | 68 | 0.100 |
Why?
|
| Animals | 6 | 2022 | 62771 | 0.090 |
Why?
|
| Acute Disease | 1 | 2016 | 2515 | 0.090 |
Why?
|
| Mice | 5 | 2022 | 35992 | 0.090 |
Why?
|
| Organoids | 2 | 2022 | 316 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 2368 | 0.080 |
Why?
|
| Male | 8 | 2021 | 128453 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 7216 | 0.070 |
Why?
|
| United States | 2 | 2022 | 15982 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2019 | 9307 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 4897 | 0.070 |
Why?
|
| Biomarkers | 1 | 2017 | 5106 | 0.070 |
Why?
|
| Risk Factors | 2 | 2020 | 17823 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 7461 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 15253 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2019 | 5685 | 0.060 |
Why?
|
| Texas | 1 | 2015 | 6415 | 0.060 |
Why?
|
| Recurrence | 2 | 2022 | 4881 | 0.050 |
Why?
|
| Seroconversion | 1 | 2021 | 18 | 0.050 |
Why?
|
| Female | 6 | 2021 | 148508 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2022 | 33827 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 360 | 0.050 |
Why?
|
| Mucin-2 | 1 | 2021 | 56 | 0.050 |
Why?
|
| Enterochromaffin Cells | 1 | 2020 | 10 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 374 | 0.050 |
Why?
|
| Receptors, Serotonin | 1 | 2020 | 59 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 403 | 0.050 |
Why?
|
| Acetates | 1 | 2020 | 122 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 321 | 0.040 |
Why?
|
| Prognosis | 1 | 2017 | 22458 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2021 | 253 | 0.040 |
Why?
|
| Metabolomics | 1 | 2022 | 507 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 580 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 675 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 758 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 2474 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1295 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2017 | 519 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 13351 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 9433 | 0.020 |
Why?
|